Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1,268,697
-
Total 13F shares
-
246,771
-
Share change
-
+246,771
-
Total reported value
-
$2,376,293
-
Price per share
-
$9.63
-
Number of holders
-
8
-
Value change
-
+$2,376,293
-
Number of buys
-
8
Institutional Holders of CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) as of Q2 2025
As of 30 Jun 2025,
CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
246,771 shares.
The largest 8 holders included
Parallel Advisors, LLC, ARCH Venture Management, LLC, UBS Group AG, FNY Investment Advisers, LLC, Tower Research Capital LLC (TRC), SBI Securities Co., Ltd., JONES FINANCIAL COMPANIES LLLP, and BANK OF AMERICA CORP /DE/.
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.